Trial of AEO in New Glioblastoma (GBM)

Clinical trial NCT04450160 · UNKNOWN

Trial details

NCT number: NCT04450160
Sponsor: MetVital, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2020-12-01
Primary completion: 2022-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.